Skip to content

Clinical trials

Phase 3 Diabetic Retinopathy trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetic Retinopathy Phase: Phase 3 Country / region: United States Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20031
20041
20051
20061
20072
20091
20112
20161
20182
20191
20203
20212
20241
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Terminated5
Recruiting2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Jaeb Center for Health Research6
Kodiak Sciences Inc4
Chromaderm, Inc.3
Merck Sharp & Dohme LLC2
Novartis2
Novartis Pharmaceuticals2
Alcon Research1
Bausch & Lomb Incorporated1
Hoffmann-La Roche1
Joslin Diabetes Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetic Retinopathy26
Macular Edema7
Eye Diseases5
Retinal Diseases5
Vision Disorders5
Retinal Degeneration4
Diabetes Mellitus3
Vision, Low2
Cardiovascular Diseases1
Diabetes Mellitus, Type 21

Trials

Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.